Murray D Krahn

Murray D Krahn, BA, MSc, MD

Dr. Murray Krahn is the Director of THETA (Toronto Health Economics and Technology Assessment Collaborative); F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto; Professor in the Faculties of Medicine and Pharmacy, University of Toronto; Senior Scientist at the Toronto General Hospital Research Institute; and Adjunct Scientist at the Institute for Clinical Evaluative Sciences, Toronto. He is also an attending physician in the division of General Internal Medicine at the University Health Network, Toronto. He completed a Master's Degree in Clinical Epidemiology at McMaster University, and a Clinical Fellowship in Medical Decision Making at the New England Medical Centre in Boston. Dr. Krahn's research program focuses on the use of decision analytic methods to examine health policy and health decision-making. He leads one of the leading technology assessment institutes in the country.
My central area of research interest has been the application of decision analysis and economic evaluation to broad questions of health and clinical policy. This methodologic focus has been expressed in a variety of content areas including prostate cancer and viral hepatitis. More recent interests include evaluating the role of disease specific utility assessment, using administrative data to build longitudinal cost models, and evaluating the role of health technology assessment in pharmaceutical reimbursement decisions.

Related Links

CMAJ Open. 2017 Aug 25;5(3):E662-E672
Wong WWL, Erman A, Feld JJ, Krahn M
Health Policy. 2017 Jun 24;:
Fasterholdt I, Krahn M, Kidholm K, Yderstræde KB, Pedersen KM
BMC Public Health. 2017 Jun 26;17(1):596
Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U
Pediatr Blood Cancer. 2017 May 13;:
de Oliveira C, Bremner KE, Liu N, Greenberg ML, Nathan PC, McBride ML, Krahn MD
J Telemed Telecare. 2017 Jan 01;:1357633X17706286
Sahakyan Y, Abrahamyan L, Shahid N, Stanimirovic A, Pechlivanoglou P, Mitsakakis N, Ryan W, Krahn M, Rac VE
Pharmacoeconomics. 2017 Apr 21;:
IJzerman MJ, Koffijberg H, Fenwick E, Krahn M
CMAJ Open. 2017 Jan-Mar;5(1):E97-E108
Wong WW, Lee KM, Singh S, Wells G, Feld JJ, Krahn M
J Wound Care. 2017 Apr 01;26(sup4):S4-S14
Chan B, Cadarette S, Wodchis W, Wong J, Mittmann N, Krahn M
Value Health. 2017 Mar;20(3):345-356
de Oliveira C, Bremner KE, Liu N, Greenberg ML, Nathan PC, McBride ML, Krahn MD
Healthc Policy. 2017 Feb;12(3):95-108
De Oliveira C, Pataky R, Bremner KE, Rangrej J, Chan KK, Cheung WY, Hoch JS, Peacock S, Krahn MD

Pages


Director of THETA (Toronto Health Economics and Technology Assessment Collaborative)
F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto
Professor in the Faculties of Medicine and Pharmacy, University of Toronto
Adjunct Scientist at the Institute for Clinical Evaluative Sciences, Toronto.